Medicines from a chain to a label

Medicines follows peptides that have been, or are being, turned into drugs. It is the topic with the firmest evidence, because approved drugs come with labels and trial data. The articles explain why most peptide drugs are injected, what each trial phase can tell you, and how a label dose differs from a number repeated on a forum.

Read why swallowing a peptide usually fails and what a clinical trial phase actually tells you first. The long road from venom to prescription shows how a natural peptide becomes a medicine, tesamorelin dosage on the label and beyond it reads one approved label closely, and retatrutide in Canada explains why a registered trial is the only legitimate route to a drug that is not yet approved.